Targeted sulfur(VI) fluoride exchange-mediated covalent modification of a tyrosine residue in the catalytic pocket of tyrosyl-DNA phosphodiesterase 1
Developing effective inhibitors of the DNA repair enzyme tyrosyl-DNA phosphodiesterase 1 (TDP1) has been challenging because of the enzyme shallow catalytic pocket and non-specific substrate binding interactions. Recently, we discovered a quinolone-binding hot spot in TDP1's active site proximal to the evolutionary conserved Y204 and F259 residues that position DNA. Sulfur (VI) fluoride exchange (SuFEx) is a biocompatible click chemistry reaction that enables acylation of protein residues, including tyrosine. Selective protein modifications can provide insights into the biological roles of proteins and inform ligand design. As we report herein, we used SuFEx chemistries to prepare covalent TDP1-bound binders showing site-specific covalent bonds with Y204. Our work presents the first application of SuFEx chemistries to TDP1 ligands. It validates the ability to covalently modify specific TDP1 residues by designed targeting and adds to the chemical biology resource toolbox for studying TDP1.
Authors
- Kiall F. Suazo (ORCID: https://orcid.org/0000-0002-0803-8332)
- Xue Zhi Zhao (ORCID: https://orcid.org/0000-0003-1006-6364)
- Yves Pommier (ORCID: https://orcid.org/0000-0002-3108-0758)
- Þorkell Andrésson (ORCID: https://orcid.org/0000-0002-9545-2450)
- Md Rasel Al Mahmud (ORCID: https://orcid.org/0000-0003-0401-3311)
- Keli Agama (ORCID: https://orcid.org/0000-0002-0505-8645)
- G.T. Lountos (ORCID: https://orcid.org/0000-0003-3463-8881)
- Terrence R. Burke (ORCID: https://orcid.org/0000-0001-9925-8586)
- Wenjie Wang (ORCID: https://orcid.org/0000-0002-3199-7785)
- I Barakat
Institutions
- National Institutes of Health (US)
- Frederick National Laboratory for Cancer Research (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
Publication Details
- Journal
- Communications Chemistry
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1038/s42004-024-01298-w
- Citations
- 6
- Primary Topic
- Cancer therapeutics and mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- U.S. Department of Energy
- U.S. Department of Health and Human Services
- Georgia Research Alliance
- National Institutes of Health
- Office of Science
- National Cancer Institute
- Argonne National Laboratory